These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7674329)

  • 1. Deadly fungal infections spreading in cancer patients.
    McCann J
    J Natl Cancer Inst; 1995 Oct; 87(19):1434-6. PubMed ID: 7674329
    [No Abstract]   [Full Text] [Related]  

  • 2. Fungal infections in patients with cancer.
    Anaissie EJ; Bodey GP
    Pharmacotherapy; 1990; 10(6 ( Pt 3)):164S-169S. PubMed ID: 2075117
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical aspects of fungal infection in organ transplant recipients.
    Hibberd PL; Rubin RH
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S33-40. PubMed ID: 7948569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer.
    Cáp J; Mojzesova A; Kayserova E; Bubánska E; Hatiar K; Trupl J; Krcméry V
    Chemotherapy; 1993; 39(6):438-42. PubMed ID: 8222873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole versus oral amphotericin B in preventing fungal infection in chemotherapy-induced neutropenic patients with haematological malignancies.
    Akiyama H; Mori S; Tanikawa S; Sakamaki H; Onozawa Y
    Mycoses; 1993; 36(11-12):373-8. PubMed ID: 7935568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and aspergillosis--has the principle been proven?
    De Pauw BE; Donnelly JP
    N Engl J Med; 2007 Jan; 356(4):409-11. PubMed ID: 17251538
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uncommon opportunistic mycoses with immune defects].
    Tomsíková A; Zavázal V; Kotál L; Kastl J
    Mykosen; 1986 Aug; 29(8):363-71. PubMed ID: 3762591
    [No Abstract]   [Full Text] [Related]  

  • 10. The pathogenesis of opportunistic mycoses in man.
    Smith JM
    Microbiol Sci; 1986 Apr; 3(4):122-5. PubMed ID: 3153152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hygienic recommendations for preventing visceral mycoses].
    Gangneux JP
    Rev Prat; 2015 Dec; 65(10):1339. PubMed ID: 26979039
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of invasive fungal infections in patients with neoplastic disease.
    Walsh TJ; Lee JW
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S468-80. PubMed ID: 8274613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fungal infections in children with malignant disease].
    Michel G
    Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
    Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N; Pedicone L; Patino H; Durrant S
    N Engl J Med; 2007 Jan; 356(4):335-47. PubMed ID: 17251530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pocket guide to invasive mycoses in onco-hematologic patients].
    Bermúdez A; Carreras E; De la Cámara R; Eraso E; Fortún J; García-Ruiz JC; Guarro J; Jarque I; Marcos de Lucas E; Mayayo E; Pastor FJ; Pemán J; Pontón J; Quindós G; Salavert M; Sanz MA; Zaragoza R
    Rev Iberoam Micol; 2009; Suppl():3-199. PubMed ID: 20143497
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifungal prophylaxis in neutropenic patients with hematologic malignancies.
    Böhme A; Karthaus M; Hoelzer D
    Antibiot Chemother (1971); 2000; 50():69-78. PubMed ID: 10874456
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of opportunistic invasive mycoses.
    Kullberg BJ; Oude Lashof AM
    Eur J Med Res; 2002 May; 7(5):183-91. PubMed ID: 12069910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of fungal and other opportunistic infections in immunocompromised patients.
    Wade JC
    Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial fungal infections. Old problems and new challenges.
    Anaissie E; Bodey GP
    Infect Dis Clin North Am; 1989 Dec; 3(4):867-82. PubMed ID: 2687366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.